NetworkNewsBreaks – Delic Holdings Corp. (CSE: D
Post# of 135
(Total Views: 218)
Posted On: 08/16/2022 3:50:10 PM
NetworkNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Names Key Management Positions
Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, have announced advanced appointments for two key executives. According to the company, Delic Holdings cofounder and CEO Matt Stang has been named executive chair while COO Kevin Nicholson has been named CEO and will also join the company’s board of directors; Nicholson will continue to serve in his current role as CEO of Ketamine Wellness Centers (“KWC”). Before founding Delic, Stang owned and operated “High Times,”a leading source of cannabis news. As Delic CEO, Stang led the company in its acquisition of KWC, becoming the nation’s largest ketamine therapy provider in the process. Under his leadership, DELCF repported more than $1.5 million in revenue last year and increased net assets 500% in its first full year of operation. In his role as CEO of KWC, Nicholson grew the company, which generated an annual revenue of more than $4 million and provided some 100,000 treatments to date. The company also noted that it has granted 4,600,000 stock options to certain officers, directors, employees and consultants to purchase 4,600,000 subordinate voting shares. “As the conversation around psychedelics evolves and gains momentum, Delic will continue to remain at the forefront,” said Delic Holdings executive chair Matt Stang in the press release. “It is a privilege to continue as the company’s executive chairman and to work closely with the prestigious board of directors under Kevin’s leadership. I am highly confident that together we will continue to guide the company in its next phase of growth and further modernize healthcare.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, have announced advanced appointments for two key executives. According to the company, Delic Holdings cofounder and CEO Matt Stang has been named executive chair while COO Kevin Nicholson has been named CEO and will also join the company’s board of directors; Nicholson will continue to serve in his current role as CEO of Ketamine Wellness Centers (“KWC”). Before founding Delic, Stang owned and operated “High Times,”a leading source of cannabis news. As Delic CEO, Stang led the company in its acquisition of KWC, becoming the nation’s largest ketamine therapy provider in the process. Under his leadership, DELCF repported more than $1.5 million in revenue last year and increased net assets 500% in its first full year of operation. In his role as CEO of KWC, Nicholson grew the company, which generated an annual revenue of more than $4 million and provided some 100,000 treatments to date. The company also noted that it has granted 4,600,000 stock options to certain officers, directors, employees and consultants to purchase 4,600,000 subordinate voting shares. “As the conversation around psychedelics evolves and gains momentum, Delic will continue to remain at the forefront,” said Delic Holdings executive chair Matt Stang in the press release. “It is a privilege to continue as the company’s executive chairman and to work closely with the prestigious board of directors under Kevin’s leadership. I am highly confident that together we will continue to guide the company in its next phase of growth and further modernize healthcare.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)